Alpha 2.0
Login Register
» Journals » J Am Acad Dermatol

Journal of the American Academy of Dermatology

The Journal of the American Academy of Dermatology is a prestigious peer-reviewed medical journal that focuses on all aspects of dermatology. It publishes cutting-edge research, clinical studies, and reviews related to the diagnosis, treatment, and prevention of skin diseases. With a wide readership of dermatologists, researchers, and healthcare professionals, it serves as a valuable resource for advancing knowledge and improving patient care in the field of dermatology.
Details
Abbr. J Am Acad Dermatol
Start 1979
End Continuing
Frequency Monthly
p-ISSN 0190-9622
e-ISSN 1097-6787
Country United States
Language English
Specialty Dermatology
Metrics
h-index / Ranks: 405 243
SJR / Ranks: 1611 1677
CiteScore / Ranks: 1928 8.70
JIF / Ranks: 255 13.8
Recent Articles
1.
Cross-sectional analysis of mental health comorbidities in patients with prurigo nodularis
Frankel D, Ma E, Gage D, Akiska Y, Shahsavari S, Kwatra S
J Am Acad Dermatol . 2025 Mar; PMID: 40089025
No abstract available.
2.
Retiform purpura
Farrukh F, Korman A
J Am Acad Dermatol . 2025 Mar; PMID: 40089024
No abstract available.
3.
Reduced Major Adverse Cardiovascular Events (MACE) with Interleukin-17 Inhibitors Compared to Methotrexate in Psoriasis Patients: A multi-center retrospective cohort analysis
Islam R, Maltese A, Islam K, Wu J
J Am Acad Dermatol . 2025 Mar; PMID: 40089023
No abstract available.
4.
Long-term Cardiovascular Safety of Ustekinumab in Psoriasis and Psoriatic Arthritis: Results from an Observational Post-Authorization Safety Study Based on Swedish National Registers
Banefelt J, Skroder H, Azzabi A, Sheahan A, Suruki R, Geldhof A
J Am Acad Dermatol . 2025 Mar; PMID: 40089022
Background: Evidence on the comparative cardiovascular safety of ustekinumab in psoriasis (PsO) and psoriatic arthritis (PsA) remains limited. Objective: To assess risk of major adverse cardiovascular events (MACE) among PsO...
5.
Differences in NIH Funding, Publications, and H-Index between Men and Women Who Are Endowed Dermatology Chairs
Abdulkader F, Khan S, Reynolds C, Rodriguez R, Oganesyan A, Dellavalle R
J Am Acad Dermatol . 2025 Mar; PMID: 40086667
No abstract available.
6.
Alar Rim Preservation Advancement (ARPA) Flap
Regester R, Sayles B, Cannella A, Rau A, Griess A
J Am Acad Dermatol . 2025 Mar; PMID: 40081666
No abstract available.
7.
Ethics of Ambient Documentation
Chambers S, Gangal A, Stoff B
J Am Acad Dermatol . 2025 Mar; PMID: 40081665
No abstract available.
8.
Mohs micrographic surgery reduces the risk of reconstruction with positive margins, repeat surgeries, and time to definitive reconstruction compared to conventional excision of hand and foot melanomas: a retrospective cohort study
Frankel D, Valdes-Morales K, Trifoi M, Lin S, Deitermann A, Banala M, et al.
J Am Acad Dermatol . 2025 Mar; PMID: 40081664
Background: Hand and foot melanomas (HFM) have increased risk for positive margins after conventional excision (CE). Mohs micrographic surgery (MMS) may improve margin clearance prior to reconstruction. Rates of reconstruction...
9.
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trials
Gooderham M, Molin S, Bissonnette R, Worm M, Crepy M, Stingeni L, et al.
J Am Acad Dermatol . 2025 Mar; PMID: 40081663
Background: There are no topical treatments that have been specifically developed and approved for moderate to severe Chronic Hand Eczema (CHE). Objective: To evaluate the long-term safety and efficacy of...
10.
Discount pharmacies may save patients significant money on androgenetic alopecia medications compared to both traditional pharmacies and direct-to-consumer companies
Ranpariya M, Lipoff J
J Am Acad Dermatol . 2025 Mar; PMID: 40074152
No abstract available.